White matter hyperintensities (WMH) are prevalent. Although arteriolar disease has been implicated in their pathogenesis, venous pathology warrants consideration. We investigated relationships of WMH with histologic venous, arteriolar and white matter abnormalities and correlated findings with premortem neuroimaging. Three regions of periventricular white matter were sampled from archived autopsy brains of 24 pathologically confirmed Alzheimer disease (AD) and 18 age-matched nonAD patients. Using trichrome staining, venous collagenosis (VC) of periventricular veins (<150 mm in diameter) was scored for severity of wall thickening and occlusion; percent stenosis by collagenosis of large caliber (>200 mm) veins (laVS) was measured. Correlations were made between WMH in premortem neuroimaging and vascular and white matter pathology. We found greater VC (U (114) ¼ 2092.5, p ¼ 0.005 and U (114) ¼ 2121.5, p ¼ 0.002 for small and medium caliber veins, respectively) and greater laVS (t (110) ¼ 3.46, p ¼ 0.001) in patients with higher WMH scores; WMH scores correlated with VC (r s(114) ¼ 0.27, p ¼ 0.004) and laVS (r s(110) ¼ 0.38, p < 0.001). By multiple linear regression analysis, the strongest predictor of WMH score was laVS (b ¼ 0.338, p < 0.0001). VC was frequent in patients with periventricular infarcts identified on imaging. We conclude that periventricular VC is associated with WMH in both AD and nonAD patients and the potential roles of VC in WMH pathogenesis merit further study.
INTRODUCTION
White matter hyperintensities (WMH) detected on magnetic resonance imaging (MRI) are prevalent in the elderly (1) and in patients with Alzheimer disease (AD) (2) . They are a subject of current interest because (i) they are frequently detected on routine MRI and computed tomography (CT) scans; (ii) they are associated with a neurobehavioral profile and are a risk factor for dementia, stroke, and falls (2-4); and (iii) they have even been described as an age-related neurodegenerative disorder (5) . The neuropathology and pathogenesis of WMH remain elusive, however, and the importance of clarifying their pathogenesis has been emphasized in recent reviews (6) . There is an epidemiological association between WMH and cerebrovascular disease, particularly hypertension, which suggests that ischemia may be a contributing factor; moreover, WMH are seen more frequently in patients with strokes or vascular dementia (7) . Deep medullary venous collagenosis (VC) is seldom described in textbooks of neuropathology or the medical literature but VC of the small deep vessels was identified in autopsy cases with WMH by Moody et al (8) . Our previous work suggests that venous insufficiency and vasogenic edema may be a factor in the development of WMH (9) and further evidence suggests that it is present in patients with cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) (10) . The imaging-pathology correlative study presented herein investigated the relationship of WMH with venous collagenosis involving deep medullary veins of different sizes, arteriolosclerosis, and myelin loss and pallor in a mixed group of autopsied patients with and without AD. In addition, our previous observations on MRI suggest that as periventricular WMH become larger and more confluent, periventricular infarcts (PVI) may also develop. Thus, we also studied PVI to characterize their histology and determine whether VC and arteriosclerosis were present.
MATERIALS AND METHODS

Study Cases
Archived cadaveric brain tissue samples were studied from patients with AD who had undergone an autopsy and were participants in the Sunnybrook Dementia Study (https:// clinicaltrials.gov/ct2/show/NCT01800214), an ethics board approved prospective longitudinal dementia study. Twentyfour AD cases were selected based on premortem T2/proton density (PD)-weighted MRI to include a range of severity of WMH. The clinical diagnosis of AD was made using National Institute of Neurological Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association criteria (11) ; the pathologic diagnosis of AD (at least Braak and Braak stage IV/VI) (12) had been confirmed at autopsy using a standard dementia neuropathology protocol (13) . AD cases with significant coexisting neuropathology such as demyelinating disease, other neurodegenerative phenomena, brain tumor or previous brain surgery were excluded. For the AD cases, APOE was genotyped by ER via the method previously described by Saunders et al (14) . The last Mini-Mental State Examination (MMSE) scores (15) of all AD participants before death were used as an estimation of the severity of dementia.
Research and ethics board approval was also obtained to examine archived cadaveric brain tissue from 18 patients without a clinical diagnosis of AD or other neurodegenerative phenomena who had premortem imaging available and had had Braak and Braak AD type pathology III/VI (12) documented at autopsy. This group was included to determine if any observed associations between VC and WMH were specific to an AD cohort or could be seen in those with other pathologic findings, that is nondementias. These nonAD patients had died and underwent general and brain autopsy at our tertiary health care center and were not selected specifically for their WMH status.
The presence of numerous risk factors for cardiovascular and cerebrovascular disease were documented for both AD and nonAD patients, including hypertension, diabetes, smoking, obesity, dyslipidemia, carotid atherosclerosis, peripheral vascular disease, coronary artery disease, and previous history of stroke. Each risk factor was classified as either present (score 1) or absent (score 0), with the sum of score representing an overall estimate of severity of cardiovascular and cerebrovascular disease risk.
The characteristics of both AD and nonAD study cases are shown in Table 1 . There were no significant differences between the AD and nonAD group in terms of age at death (72.8 vs 76.3 years, p ¼ 0.28) or sex (62% male vs 61% male) ( Table 2 ).
Brain Imaging and WMH Quantification
Premortem MRI results closest to the date of death were used to quantify WMH; the mean interval between neuroimaging and death for all subjects was 1.6 years. MRI was performed with a 1.5-T scanner (GE Medical systems, Milwaukee, WI). T2/PD-weighted images (3-mm-thick interleaved slices, axial spin echo, with TR/TE, 3000/30-80 ms; 0.5 NEX, 20 Â 20 cm FOV, 0.78 Â 0.78 mm in-plane resolution) and 3-dimensional T1-weighted images (SPGR with TR/TE,  35/5ms; 35 flip angle, 1 NEX, 22 Â 16.5 cm FOV, 0.86 Â 0.86 mm in-plane resolution, and 1.2-1.4-mm slice thickness) were acquired. All AD cases and 7 nonAD cases had MRIs available. Eleven of the 18 nonAD patients did not have MRI studies but premortem head CT scans were available; all brain CT scans were obtained using high speed VCT CT scanner (GE Medical Systems), with in-plane resolution 0.48 Â 0.49 mm and 2.5-5 mm slice thickness.
White matter hyperintensities were rated on PD-weighted MRI (or CT) that corresponded to the 3 levels from which the periventricular white matter tissues were sampled for pathologic examination (i.e. anterior, middle, and posterior periventricular white matter) (Fig. 1A, C) . WMH were rated on each of these 3 periventricular areas by consensus of 2 experienced observers (R.N., a neurologist; F.G., a research neuroradiologist), who were blinded to clinical and pathology data. Periventricular WMH were scored using the 3-point scale of Fazekas et al (16) with 0 ¼ absent, 1 ¼ caps or thin lining, 2 ¼ band or halo, and 3 ¼ extending to the deep white matter (Fig. 1B) .
Volumetric analysis of WMH in those with MRI scans was performed using our previously described computerized segmentation technique, Lesion-Explorer, which automatically generated overall WMH volumes (17) . The WMH volumes were obtained by authors blinded to clinical and pathology data.
Tissue Sampling and Histology for Assessment of WMH (Primary Analysis)
Three coronal plane blocks of white matter were sampled from archived formalin-fixed autopsy brain tissue for each case as follows: anterior periventricular white matter (at the level of nucleus accumbens), middle periventricular white matter (at the level of the mammillary body), and posterior periventricular white matter (at the level of the splenium of the corpus callosum) (Fig. 1A) . The tissue blocks were taken from the same anatomical regions as those analyzed on imaging. One hundred twenty-six tissue blocks were sampled for histology: 72 from the 24 AD cases and 54 from the 18 nonAD cases. The blocks were embedded in paraffin, cut into 4-mm-thick sections, and stained with hematoxylin and eosin with Luxol fast blue (H&E/LFB) and Gomori and Masson's trichrome stains.
AD pathology was staged in each case according to Braak and Braak (12) by examining the middle frontal gyrus, superior and middle temporal gyri, hippocampus and inferior parietal lobule using tau (AT8) immunohistochemistry. The CERAD age-related plaque score for each case was determined by examining the middle frontal gyrus, superior and middle temporal gyri, and inferior parietal lobule stained with Bielschowsky's method (12) .
Immunohistochemical antibodies and methods are presented in Table 3 . The histology slides were examined by a single neuropathologist (J.K.) who was blinded to the patients' neuroimaging results during the primary analysis relating to VC.
Assessment of Vasculature
For each white matter region, H&E/LFB-and trichromestained slides were used to assess the veins within 0.5 cm of the ventricular surface. VC was visible as a lightly basophilic expansion of the vessel walls on H&E/LFB ( Fig. 2A) . The collagen stained green with Gomori trichrome (Fig. 2B) and blue with Masson's trichrome; endothelia were intact. Because results from the Gomori and Masson's trichrome staining methods were comparable, the former was used for scoring. On Gomori trichrome slides, the 3 veins of largest diameter (usually >200 mm) were photographed. The maximal external and *Cardiovascular and/or cerebrovascular disease (CVD) condition or risk factor scores based on the presence of: hypertension, dyslipidemia, coronary artery disease, stroke, carotid artery disease (including myocardial infarction), congestive heart failure, peripheral vascular disease, diabetes and obesity. Each condition or risk factor was determined as either present (score 1) or absent (score 0) with the sum of score representing the severity (max ¼ 10). # WMH (white matter hyperintensities) score was the sum score of the anterior, middle and posterior periventricular WMH scores (max ¼ 9), using the Fazekas 3-point scale (16) . Independent t test was used to test the differences for the continuous measure of age and large vein stenosis. Nonparametric independent Mann-Whitney U test was used to test group differences for the ranked measures of WMH scores, WM pallor, and VC scores. Chi-square analysis tested frequency differences for the categorical measure of sex, amyloid angiopathy and arteriolosclerosis.
WM, white matter; WMH, white matter hyperintensities on brain imaging; VC, venous collagenosis. dWM, deep white matter; pvWM, periventricular white matter; AD, Alzheimer disease. (7) as follows: 0-normal thin walled veins; 1-greater than 10 veins counted with thickened walls but lumen remains at least 75% of the total vessel diameter; 2-greater than 10 veins counted with thickened walls but lumen remains at least 50% of the total vessel diameter; 3-greater than 10 veins with venous occlusion or severe stenosis (Moody grade 3) (Fig. 2C ). Sixteen cases underwent immunohistochemical staining for smooth muscle actin (SMA) in attempts to ascribe lineage of the periventricular small vessels; arterioles were identified by having a continuous wreath of concentric smooth muscle on SMA immunostaining (18) . Using the criteria of smooth muscle loss and medial deposition of fibrohyaline material within arterioles measuring less than approximately 300 mm, the presence or absence of arteriolosclerosis within the deep white matter and within the basal ganglia of each case was determined (19) (20) (21) .
The presence of amyloid angiopathy was documented as follows: sections of periventricular white matter were immunostained for b-amyloid to confirm absence of amyloid in the periventricular vessels. Three cortical sections (frontal, temporal and occipital) from each case were also immunostained for b-amyloid and the presence of cortical and leptomeningeal amyloid angiopathy was graded using immunohistochemistry and H&E/LFB-stained sections following Vonsattel et al (22) . For one case, b-amyloid immunohistochemistry was not available and Congo red staining was examined instead, and in 4 cases, only a single cortical section was immunostained for b-amyloid. For each case, H&E and b-amyloid immunostained cortical sections were also examined to exclude amyloid angiitis; the presence of recent or previous cortical hemorrhages was recorded.
Assessment of White Matter
From each region of white matter, the severity of myelin loss and pallor on H&E/LFB staining was assessed semiquantitatively as 0 (normal myelin) to 3 (severe myelin loss) in both the periventricular white matter and deep subcortical white matter (more than 1.0 cm from the ventricular surface).
Tissue Sampling and Histology for Assessment of PVI (Secondary Analysis)
Of the 24 AD patients, 6 were identified as having PVI on MRI. PVI are considered one manifestation of small vessel disease and this was defined as a hypolucent area (>3 mm in diameter) on a T1-weighted MRI, with signal intensity similar to CSF on T2/PD-weighted MR images, and in close proximity to the ventricles (Fig. 3) . A total of 14 PVI were identified within this cohort of 6 patients. T1-weighted MRI was used for anatomical localization of PVI in formalin-fixed coronally sectioned archived cadaveric brain tissue; whether the lesions were grossly visible was documented. Thirty tissue blocks were created for pathological assessment of the 14 PVI. Sections were stained with H&E/LFB, Masson's trichrome, immunohistochemistry for GFAP, CD68 and neurofilament to identify histologic correlates of the PVI. The presence of infarcts was confirmed if the following were seen: loss of neural parenchyma on H&E/LFB, and axonal loss on neurofilament, histiocytes on CD68 or gliosis on GFAP immunostaining, respectively. The presence of atherosclerosis, arteriosclerosis and VC was assessed as above. Based on histological results, the lesions were classified as either histologically confirmed infarcts, dilated perivascular spaces or no significant histologic abnormalities.
Statistical Analysis
Data analyses were performed using SPSS v. 21 (IBM, SPSS Inc., Chicago, IL). The significance of differences in subject demographic characteristics, brain-imaging and pathological features was assessed using nonparametric MannWhitney U or Kruskal-Wallis H test for the nonnormally distributed ranked variables. The Student t test or one-way ANOVA were used for continuous variables and Chi-Square test was used for categorical variables. Spearman correlation coefficient analysis was used for relationships between WMH scores and vascular and white matter pathologies. Linear regression was used to model the probability of WMH on neuroimaging as function of vascular and white matter pathologies. Specifically, the first model included the Fazekas score (ie semiquantitative burden of WMH from each anatomical area) as the dependent variable with the following independent variables: small vein VC, medium vein VC, percent stenosis of large veins (laVS), arteriosclerosis, amyloid angiopathy, and white matter pallor. The second model included global Fazekas scores or log-transformed total WMH volumes (because WMH volumes have a nonnormal distribution) as the dependent variable along with the same independent variables covariating cerebrovascular and cardiovascular risk and/or severity of dementia by MMSE. Only data from those patients with MRIs was included in the second analysis. The a value for statistical significance was set at 0.05.
RESULTS
Study Subjects
Characteristics of the 24 AD and 18 nonAD subjects are shown in Table 1 . There were no significant differences between the clinical, imaging or pathologic parameters of the AD versus the nonAD groups (Table 2) .
Amyloid angiopathy (if categorized as present or absent) was more frequent in AD (62.5%) than in controls (33.3%) (v in imaging or pathology measures based on presence or absence of APOE E4.
WMH Scores on Brain Imaging
Severity of WMH on MRI or CT images was rated from 0 to 3 (Fazekas scale) at regions corresponding to the blocks where pathological sections were sampled; 72 MRI slices were independently examined from 24 AD cases and 54 image slices from 18 nonAD cases. There was a broad distribution of WMH scores (Fig. 4A) 
Vascular Pathology of WMH
Arteriolosclerosis was present in either the deep white matter or basal ganglia in 18 of the subjects (13 AD and 5 non-AD cases). Amyloid angiopathy was frequently seen by bamyloid immunostaining (present in 21 study cases, 15 AD, and 6 nonAD). As per the Vonsattel grading system, 8 of the AD cases had mild and 7 cases had moderate amyloid angiopathy, while in the nonAD cohort, 4 cases had mild and 2 had moderate amyloid angiopathy. There was no amyloid seen in any of the periventricular vessels. There were no cases of amyloid angiitis and 1 AD patient (number 5) had a previous cortical hemorrhage.
Small vein collagenosis (sVC) and medium vein collagenosis (mVC) were a frequent finding in both AD and nonAD groups (Fig. 4B, C) . The collagenized veins lacked a continuous wreath of SMA-immunopositive muscle cells (Fig. 2C, D) , and in fact few vessels were present in the immediate periventricular regions (0.5 cm) of any of the cases that had a continuous concentric wreath of smooth muscle; this is in keeping with Moody et al (8) . laVS was also a common finding (Fig. 4D) , and stenoses ranged from 3.0% to 69.0% with an overall mean of 20.1%.
Correlations Between WMH Imaging Scores, Vascular, and White Matter Pathology
Relationships between WMH scores on imaging and vascular and white matter pathologies are presented below and in Tables 4 and 6 and Figures 5 and 6 .
Vonsattel amyloid angiopathy scores correlated with CERAD AD pathology scores (r ¼ 0.449, p ¼ 0.003), scores of cerebro-/cardiovascular risk factor severity (r ¼ À0.328, p ¼ 0.034) and global white pallor scores (r ¼ 0.359, p ¼ 0.023). Amyloid angiopathy scores did not correlate with global Fazekas WMH scores, sVC, mVC, or laVS (p > 0.05), using Spearman's correlation (n ¼ 42).
As shown in Table 4 and Figure 5 , the VC scores and laVS increased in parallel with increasing WMH scores. Using nonparametric Kruskal-Wallis tests, there were significant differences between the WMH scores by VC of both small and medium caliber veins (H (3) ¼ 8.54, p ¼ 0.036 and H (3) ¼ 12.3, p ¼ 0.006, respectively) ( Fig. 5A ) and by laVS, using one-way ANOVA (F (3) ¼ 6.07, p ¼ 0.001) (Fig. 5B) . When the WMH scores were dichotomized into low WMH versus high WMH, several significant differences were found in the white matter and vascular pathology between these 2 groups ( (Fig. 6A) ; (iii) collagenosis of both the small and medium caliber periventricular veins was more severe in the high WMH group (U (117) ¼ 1205.5, p ¼ 0.005, and U (117) ¼ 1146.0, p ¼ 0.001, respectively, by Nonparametric Mann-Whitney U test, (Fig. 6B) ; and (iv) the laVS was significantly greater in the high WMH group (t (113) ¼ 3.56, p ¼ 0.001) (Fig. 6C) .
Using Spearman's correlation testing there were several significant correlations between WMH scores and pathologic measures of white matter and vasculature as shown in Table 6 . When all subjects were combined, WMH scores significantly correlated with periventricular white matter pallor (r s(116) ¼ 0.252, p ¼ 0.006), collagenosis scores of both small and me- (A-C) Bar charts illustrating the differences between the low and high white matter hyperintensities (WMH) groups in white matter pallor (A) and venous collagenosis of small and medium caliber veins (B) (using nonparametric independent Mann-Whitney U test), and percent of large caliber vein stenosis (C) (using t test). Error: 95% confidence interval. The low WMH group (n ¼ 57) is defined as the Fazekas WMH scores 1; high WMH group (n ¼ 63) is defined as the Fazekas WMH scores >1. Based on the first linear regression model using pathological measures of white matter pallor, arteriosclerosis, amyloid angiopathy score, VC of the small and medium caliber veins and laVS to predict WMH score, the strongest predictor of WMH score (rated on 126 anatomical sections) was the laVS (b ¼ 0.338, df ¼ 114, p < 0.0001). Similarly, in the second model using global measures with cerebro-/ cardiovascular disease risk factors as covariants, the most significant predictor of the globally summed Fazekas scores (measured on 42 subjects) was also the laVS (b ¼ 0.379, df ¼ 39, p ¼ 0.018), and the most significant predictor of the log-transformed total WMH volumes (measured on 31 out of 40 subjects) was white matter pallor (b ¼ 0.461, df ¼ 28, p ¼ 0.035). Separately, to examine how the severity of AD would affect the second models, we used MMSE as the covariant; the laVS and white matter pallor were the predic- 
PVI
The 6 AD subjects having PVI were 2 men and 4 women who were 78 6 3.9 years old. Fourteen PVI were identified on MRI, with 5 having round and 9 having oval or linear shapes. On imaging they were located from 0 to 6 mm from the surface of the lateral ventricle, ranged from 3 to 10 mm in diameter, 12/14 were within periventricular patchy or confluent WMH, and 13/14 overlaid a periventricular linear structure, presumably a deep medullary vein (Fig. 3) . On pathologic examination, 5 lesions out of 14 were grossly visible at autopsy, 3 were histologically confirmed as infarcts, 2 were dilated perivascular spaces, and one subject with PVI had arteriolosclerosis.
The average VC rating for small and medium caliber veins in the PVI cohort was 1.6 and 0.92, respectively, and laVS was 31.1% in the patients with PVI on imaging (Fig. 7) . For histologically confirmed infarcts, the average rating for sVC and mVC was 2.3 and 0.8 (out of 3), and the average laVS was >30%.
DISCUSSION
WMH, also known as "leukoariosis", are detected by neuroimaging. They are common in individuals older than Chi-square tested proportional differences for arteriolosclerosis; nonparametric Mann-Whitney U test group differences for WM pallor and VC scores. Student t test for group difference for % large vein stenosis.
dWM, deep white matter; pvWM; periventricular white matter; WMH, white matter hyperintensities on brain imaging; VC, venous collagenosis.
65 years and were frequently found in our nonAD study cohort. The prevalence of WMH increases with age (1, (23) (24) (25) (26) and WMH can be associated with cognitive dysfunction and age related disability (21, (27) (28) (29) (30) . A recent meta-analysis of nearly 1000 prospective studies confirmed an increased risk of cognitive decline, dementia, stroke, and death in the setting of WMH (4). Despite their prevalence, the etiology and neuropathology of WMH remain elusive; models of proposed pathogenesis have been put forth and continue to evolve (21, 31) , but some components remain speculative. The need to clarify the pathogenesis of WMH was nicely articulated in a recent review (6) . Studies searching for the pathologic correlate of WMH have reported a variety of histologic abnormalities within the affected white matter (6, 32, 33) , including: (i) rarefaction of myelin and axons (34) and severe myelin attenuation (35) (36) (37) (38) ; (ii) increased microglia/macrophages (39, 40) ; and (iii) changes in glial cells including decreased numbers of oligodendroglia (41), apoptotic oligodendroglia (42), astrocytosis (34, 43) , and clasmatodendrosis (34, 35, 44) . The most recent and comprehensive study by Murray et al used quantitative digital imaging analysis to score various pathologic parameters in white matter lesions identified by postmortem FLAIR MRI in cognitively normal aged adults without neurodegenerative phenomena at autopsy (45) . They reported that myelin loss contributed to white matter vacuolation and ultimately WMH. Our study further supports myelin loss as a prominent feature of WMH because (i) the severity of periventricular white matter pallor on histology was worse in the presence of higher WMH scores (p ¼ 0.054); (ii) when the WMH were dichotomized, periventricular white matter pallor was significantly worse in the high WMH group (Nonparametric MannWhitney U test, p ¼ 0.030); and (iii) by linear regression, the most significant predictor of log-transformed total WMH volume was white matter pallor on histology (b ¼ 0.461, df ¼ 28,
Most theories of pathogenesis of WMH focus on vascular etiologies but a few nonvascular ideas warrant mention. Axonopathy may be a contributing factor; WMH by postmortem imaging has been shown to correlate with Braak and Braak neurofibrillary stage, suggesting dying-back phenomena of the axons from tangle laden cortical neurons (46) . The extent of white matter rarefaction seen in fronto-temporal lobar degeneration with globular glial inclusions suggests that a primary disorder of oligodendroglia is also sufficient to cause extensive white matter rarefaction (47) .
There is formidable evidence linking cerebrovascular disease and WMH. Importantly, the distribution of WMH affects borderzone areas in the superior frontal and parietal regions where the penetrating arterioles end some distance from the ventricle and perfusion is normally reduced (48) . SPECT studies support this notion because there is lower perfusion within WMH than in normal-appearing white matter (49) . WMH have been shown to contain plasma proteins (eg fibrin and albumin), implying blood-brain barrier leak, as well as increased hypoxia-induced transcription factors and proteins implicating chronic hypoperfusion in their genesis (23); some pathology studies also describe small venous infarcts in the affected white matter (34) .
There is some evidence linking the development of WMH with atherosclerosis of large caliber arteries, including intracranial arteries such as the internal carotid and vessels of the Circle of Willis (50, 51) . Our study does not contribute to this body of literature because we did not systematically document the presence or extent of intra or extracranial atherosclerosis. The role of large caliber artery pathology in this condition remains unresolved. Instead, much of the present focus is on the role of small caliber vessels and WMH are increasingly thought of as a consequence of small vessel disease (6, 21) . Few studies have investigated structural histologic abnormalities of the vessels within WMH and these have studied almost exclusively the arterial system, however. The most widely reported vascular pathology within WMH is arteriolosclerosis (34, 43) and arteriolosclerosis was the strongest correlate of WMH accumulation in a recent postmortem study by ErtenLyons et al (43) . Our study corroborates this finding because arteriolosclerosis was more frequently present in the high WMH group (X 2 (1, N ¼ 120) ¼ 5.79, p ¼ 0.016). Other arterial histologic abnormalities that have been described within WMH are arteriolar tortuosity (52) and decreased arteriolar density (45). The above-described pathologic abnormalities within white matter and arterioles have informed the development of proposed unifying models for the pathogenesis of WMH (21, 31) .
The term "venous collagenosis" is beginning to be introduced into the small vessel disease lexicon (20, 21, 31, 50) , but this phenomena has been scarcely studied and is hardly mentioned in neuropathology texts and literature. The role of the veins in the development of WMH is unaddressed by current models (21, 31) , and only a single group has investigated venous pathology in the setting of WMH, and that was over 20 years ago (8) . Moody et al studied the periventricular venous system in 22 autopsy brains of various ages and found that 65% of subjects older than 60 years had at least 50% stenosis of periventricular veins; of those, 77% with severe VC had severe leukoaraiosis and 77% of those with leukoaraiosis had at least grade 2 VC (8). Although Moody et al did not formally stratify their results by the caliber of the collagenized veins, they concluded that occlusion of multiple small veins is potentially more serious than occlusion of large veins and dural sinuses because of less collateral flow (8) .
Collagenosis of veins less than 150 mm in diameter, as well as significant stenosis of veins greater than 200 mm in diameter, were frequently encountered in our study cohort (Fig.  4B, C) . Our results support a strong association between this venous pathology and the presence of confluent WMH on MRI. VC of both small and medium caliber veins and laVS were all significantly greater in the presence of higher WMH scores (p ¼ 0.04, 0.008, and 0.001, respectively). When WMH were dichotomized into low versus high groups, collagenosis of both the small and medium caliber periventricular veins were significantly worse in the high WMH group (p ¼ 0.005 and 0.002, respectively, by nonparametric Mann-Whitney U test) and the mean laVS was significantly greater in the high WMH group (p ¼ 0.001 by Student t test). WMH scores significantly correlated with collagenosis scores of both small and medium caliber veins (p ¼ 0.004, respectively) and laVS (p ¼ 0.001) in all subjects by Spearman's correlation tests. Furthermore, the strongest predictor of WMH score by linear regression modeling was the laVS (b ¼ 0.338, df ¼ 114, p < 0.0001), and the most significant predictor of the globally summed Fazekas scores was also the laVS (b ¼ 0.379, df ¼ 39, p ¼ 0.018). Our description of histologically confirmed stenosis of the large caliber deep medullary veins in the setting of WMH is novel. Interestingly, a recent susceptibility weighted imaging study described a significant relationship between WMH volumes and visibility of the large deep medullary veins, which could be an imaging manifestation of VC (53) .
Ours is the second study suggesting an association between VC and WMH, but are they related causally? Moody et al hypothesized that venous collagenosis could alter the normal outflow of venous blood by shunting blood away from the internal cerebral vein and towards the cerebral medullary veins, and that this increased flow could cause perivenous edema (54) . Our study did not specifically study mechanism but our results implicate collagenosis of various caliber veins in the generation of WMH. We suggest that the collagenosis could (i) render large caliber veins more rigid potentially decreasing the venous pulsation and propulsion of perivenous interstitial fluid flow (55, 56) ; (ii) damage the perivenous spaces, which are potentially important channels acting as cerebral lymphatics (57); (iii) interrupt or block local or regional interstitial fluid flow; and/or (iv) cause small and medium sized veins to become leaky and less able to absorb interstitial fluid, all of which could manifest as focal or diffuse WMH. These mechanisms may be especially important in the context of AD because previous work has noted greater dilatation of perivascular spaces in the white matter of AD patients versus controls. This correlated with the burden of cortical betaamyloid, suggesting that failure of drainage of interstitial fluid from the white matter may be implicated in decreased clearance of toxic ab40-42 peptides (55, 58) .
How can one reconcile these findings of venous pathology with the previously documented arterial abnormalities in WMH? Moody et al stated that VC could decrease blood flow to the deep white matter through increased vascular resistance (8, 54) . We agree with this notion and also suggest that venous insufficiency could result in ischemic stress from impaired clearance of cellular metabolic byproducts. VC may be a reaction to reduced blood flow to the periventricular white matter and also in turn exacerbate that reduced flow through increased venous resistance. Risk factors such as hypertension and diabetes could facilitate the codevelopment of arteriolar sclerosis and VC (59) .
A significant limitation to our study was the use of formalin-fixed rather than fresh brain tissue, which precluded using the alkaline phosphatase technique to distinguish arterioles from venules (60), as employed by Moody et al (8) . We maintain, however, that the large caliber collagenized vessels are unequivocally veins by location and morphology. The collagenized <150-mm vessels we describe are most likely veins because the periventricular regions are notable for a rich venous plexus and are likely relatively devoid of small arteries and arterioles, particularly in anterior and posterior ventricular angles (48) . This phenomenon is supported by the paucity of vessels with a concentric rim of SMA immunopositivity in the 0.5 cm of periventricular white matter seen in our cases (a 100-mm arteriole should have 1 to 2 layers of smooth muscle cells) (20, 21) . We acknowledge that a sclerotic arteriole may lack a robust media with collagen replacing the smooth muscle, as integral to the process of arteriolosclerosis (19, 20) , and concede that pathologists may struggle to distinguish between a collagenized <150-mm vein and arteriolosclerosis in routine stains. Indeed, the assumption that these collagenized veins represent arteriolosclerosis by neuropathologists may be a contributing factor to both the relative lack of awareness of venous collagenosis as an entity and the frequent descriptions of arteriolosclerosis in the context of WMH (34, 43) . The smallest caliber collagenized vessels we observed may actually be capillaries; collagenosis of capillaries has not been previously described. Our findings lead us to recommend that neuropathologists carefully contemplate the lineage of affected vessels observed in the setting of small vessel disease. The pathologist's task of ascribing lineage to a diseased small vessel is aided by reflections on vascular neuroanatomy; in borderzone areas around the anterior and posterior horns of the lateral ventricles, penetrating arteries end at a significant distance from the ventricular surface; thus, the vessels running toward the ventricular surface in these regions are likely venules. Although SMA immunostaining can also aid in ascribing the correct vascular lineage, the task remains challenging due to the histologic similarity, the potential coexistence of arteriolar and venous pathologies, and the lack of widely accepted and employed histology-based definitions for various forms of small vessel disease (6, 61, 62) . A second limitation of our study was the use of premortem rather than postmortem neuroimaging and the 1.5-year average interval between our patients' imaging and death. However, because of the slow evolution of WMH at an approximate rate of 0.25 cm 3 /year (63), our patients' WMH would not be expected to change substantially in volume or score over 1.5 years.
Another observation of note is that periventricular black holes (or lacunar infarcts) in cerebral small vessel disease are usually assumed to be due to ischemia due to arteriolar occlusion (64) . However, in this study, arteriolosclerosis was not frequently seen in the regions with PVI. Rather, VC of both small and large caliber veins was a frequent finding in the PVI cohort and was especially common and severe when infarction was histologically confirmed (ie histologically confirmed infarcts had an average rating of 2.25 and >30% stenosis for small and large veins, respectively). The stenosis of small and large veins may be a potential pathogenic mechanism underlying periventricular WMH with PVI. Periventricular venous infarction is a distinct and common variety, accounting for 22% of presumed ischemic stroke and 75% of subcortical periventricular lesions in perinatal stroke (65) . It has been underinvestigated in aging and dementia. The focal round, oval or linear cystic features, mostly overlaid with periventricular medullary vasculature, in correlative premortem MRIs in our PVI are consistent with medullary venous territory infarction of the periventricular white matter, as seen in a perinatal ischemic stroke study (65) . Our study of PVI was limited by sample size and more studies in a large series with postmortem MRI guidance are warranted.
In conclusion, collagenosis of the deep medullary veins is associated with WMH in patients with and without AD. The role of VC in the genesis and evolution of WMH warrants further study, and the inclusion of the term "venous collagenosis" in discussions of small vessel disease may be justified.
